Use of tylvalosin as antiviral agent

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9066964
APP PUB NO 20100010080A1
SERIAL NO

12373657

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to the use of a macrolide antibiotic, tylvalosin, as an anti-viral agent. Tylvalosin is particularly useful for the treatment of PRRSV.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CAMBRIDGE UNIVERSITY TECHNICAL SERVICESTHE OLD SCHOOLS TRINITY LANE CAMBRIDGE CB2 1TS
ECO ANIMAL HEALTH LIMITED78 COOMBE ROAD NEW MALDEN KT3 4QS

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Brown, Thomas David Kay Cambridge, GB 3 11
Mockett, Albert Philip Adrian New Malden, GB 2 7
Stuart, Amanda Denise Cambridge, GB 2 7

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 30, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00